*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| C861 - Hepatosplenic T-cell lymphoma - as a primary diagnosis code | C861 - Hepatosplenic T-cell lymphoma - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 10.21 | |
| Readmission Rate (%) | 55.0 | |
| Unplanned Readmission Rate (%) | NA | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 840: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|
| Total Hospitalizations at DRG | 29,081 |
| Total Hospitalizations with ICD C861 - Hepatosplenic T-cell lymphoma | 11 |
| DRG Share of Total Hospitalizations | 0.09 |
| % of Total ICD C861 - Hepatosplenic T-cell lymphoma in DRG | 42.31 |
| Avg LOS at DRG | 9.8 |
| Avg LOS with ICD C861 - Hepatosplenic T-cell lymphoma | 13.27 |
| Readmission Rate at DRG | 37.3 |
| Readmission Rate with ICD C861 - Hepatosplenic T-cell lymphoma | NA |
| Unplanned Readmission Rate at DRG | 22.57 |
| Unplanned Readmission Rate with ICD C861 - Hepatosplenic T-cell lymphoma | NA |
| Total Medicare payments at DRG | $683,745,757 |
| Total Medicare payments with ICD C861 - Hepatosplenic T-cell lymphoma | $409,771 |
| Total Medicare payment per Day at DRG | $2,399 |
| Total Medicare payment per Day with ICD C861 - Hepatosplenic T-cell lymphoma | $2,807 |
| Total Medicare payment per Hospitalization at DRG | $23,512 |
| Total Medicare payment per Hospitalization with ICD C861 - Hepatosplenic T-cell lymphoma | $37,252 |
| Total Medicare Charges at DRG | $3,049,100,784 |
| Total Medicare Charges with ICD C861 - Hepatosplenic T-cell lymphoma | $2,271,153 |
| Avg Charges at DRG | $104,849 |
| Avg Charges with ICD C861 - Hepatosplenic T-cell lymphoma | $206,468 |
| Mortality Rate at DRG | 13.07 |
| Mortality Rate with ICD C861 - Hepatosplenic T-cell lymphoma | NA |
| SNF Discharge Rate at DRG | 16.93 |
| SNF Discharge Rate with ICD C861 - Hepatosplenic T-cell lymphoma | NA |
| Home Discharge Rate at DRG | 29.4 |
| Home Discharge Rate with ICD C861 - Hepatosplenic T-cell lymphoma | NA |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 840: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|
| Total Hospitalizations at DRG | 29,081 |
| Total Hospitalizations with ICD C861 - Hepatosplenic T-cell lymphoma | 11 |
| DRG Share of Total Hospitalizations | 0.09 |
| % of Total ICD C861 - Hepatosplenic T-cell lymphoma in DRG | 11.34 |
| Avg LOS at DRG | 9.8 |
| Avg LOS with ICD C861 - Hepatosplenic T-cell lymphoma | 13.27 |
| Readmission Rate at DRG | 37.3 |
| Readmission Rate with ICD C861 - Hepatosplenic T-cell lymphoma | NA |
| Unplanned Readmission Rate at DRG | 22.57 |
| Unplanned Readmission Rate with ICD C861 - Hepatosplenic T-cell lymphoma | NA |
| Total Medicare payments at DRG | $683,745,757 |
| Total Medicare payments with ICD C861 - Hepatosplenic T-cell lymphoma | $409,771 |
| Total Medicare payment per Day at DRG | $2,399 |
| Total Medicare payment per Day with ICD C861 - Hepatosplenic T-cell lymphoma | $2,807 |
| Total Medicare payment per Hospitalization at DRG | $23,512 |
| Total Medicare payment per Hospitalization with ICD C861 - Hepatosplenic T-cell lymphoma | $37,252 |
| Total Medicare Charges at DRG | $3,049,100,784 |
| Total Medicare Charges with ICD C861 - Hepatosplenic T-cell lymphoma | $2,271,153 |
| Avg Charges at DRG | $104,849 |
| Avg Charges with ICD C861 - Hepatosplenic T-cell lymphoma | $206,468 |
| Mortality Rate at DRG | 13.07 |
| Mortality Rate with ICD C861 - Hepatosplenic T-cell lymphoma | NA |
| SNF Discharge Rate at DRG | 16.93 |
| SNF Discharge Rate with ICD C861 - Hepatosplenic T-cell lymphoma | NA |
| Home Discharge Rate at DRG | 29.4 |
| Home Discharge Rate with ICD C861 - Hepatosplenic T-cell lymphoma | NA |